AU2001236065A1 - Antiviral compounds - Google Patents

Antiviral compounds

Info

Publication number
AU2001236065A1
AU2001236065A1 AU2001236065A AU3606501A AU2001236065A1 AU 2001236065 A1 AU2001236065 A1 AU 2001236065A1 AU 2001236065 A AU2001236065 A AU 2001236065A AU 3606501 A AU3606501 A AU 3606501A AU 2001236065 A1 AU2001236065 A1 AU 2001236065A1
Authority
AU
Australia
Prior art keywords
antiviral compounds
antiviral
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001236065A
Inventor
Nobutaka Fujii
Hideki Nakashima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001236065A1 publication Critical patent/AU2001236065A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2001236065A 2000-03-03 2001-03-02 Antiviral compounds Abandoned AU2001236065A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000059495 2000-03-03
JP2000-59495 2000-03-03
PCT/JP2001/001642 WO2001064716A1 (en) 2000-03-03 2001-03-02 Antiviral compounds

Publications (1)

Publication Number Publication Date
AU2001236065A1 true AU2001236065A1 (en) 2001-09-12

Family

ID=18579937

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001236065A Abandoned AU2001236065A1 (en) 2000-03-03 2001-03-02 Antiviral compounds

Country Status (2)

Country Link
AU (1) AU2001236065A1 (en)
WO (1) WO2001064716A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8435939B2 (en) 2000-09-05 2013-05-07 Biokine Therapeutics Ltd. Polypeptide anti-HIV agent containing the same
AU2001284419A1 (en) 2000-09-05 2002-03-22 Seikagaku Corporation Novel polypeptides and anti-hiv drugs containing the same
WO2004020462A1 (en) 2002-08-27 2004-03-11 Fujii, Nobutaka Cxcr4 antagonist and use thereof
WO2008075371A2 (en) 2006-12-21 2008-06-26 Biokine Therapeutics Ltd. T-140 peptide analogs having cxcr4 super-agonist activity for immunomodulation
ES2462517T3 (en) 2009-06-14 2014-05-23 Biokine Therapeutics Ltd. Peptide therapy to increase platelet levels
US9439942B2 (en) 2012-04-24 2016-09-13 Biokine Therapeutics Ltd. Peptides and use thereof in the treatment of large cell lung cancer
US10786547B2 (en) 2015-07-16 2020-09-29 Biokine Therapeutics Ltd. Compositions, articles of manufacture and methods for treating cancer
BR112018016924A2 (en) 2016-02-23 2019-01-02 Biokine Therapeutics Ltd treatment regimen selection method for individual who has acute myeloid leukemia (LMA), acute response myeloid leukemia (LMA) treatment maximization method, lma treatment method, cxcr4 antagonist, and chemotherapeutic agent in the treatment of lma
WO2020101032A1 (en) * 2018-11-16 2020-05-22 味の素株式会社 Method for producing cyclized peptide having intramolecular s-s bond

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01153699A (en) * 1987-12-11 1989-06-15 Takeda Chem Ind Ltd Novel peptide and production thereof
AU6470590A (en) * 1989-10-23 1991-04-26 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides

Also Published As

Publication number Publication date
WO2001064716A1 (en) 2001-09-07

Similar Documents

Publication Publication Date Title
AU2002221344A1 (en) Antiviral agents
AU2002225730A1 (en) Compounds
AU2002218266A1 (en) Novel indanylidene compounds
AU2001254546A1 (en) Aminopiperidines
AU2000267458A1 (en) Hypercomputer
AU2001292518A1 (en) Novel compounds
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2001266345A1 (en) Five-membered-ring compound
AU2001258349A1 (en) Bisacylguanidine
AUPQ661800A0 (en) Insulin-potentiating compounds
AU2001239765A1 (en) Novel compounds
AU2001246998A1 (en) Novel compounds
AU2001253362A1 (en) Novel compounds
AU2001265871A1 (en) Substituted sulfonylaminopyrimidines
AU2002231077A1 (en) Novel compounds
AU2001254731A1 (en) Substituted phenyluracils
AU2001256964A1 (en) Novel compounds
AU2001258255A1 (en) Substituted benzoylcyclohexenones
AU2002225724A1 (en) Motilide compounds
AU2001236065A1 (en) Antiviral compounds
AU2002217285A1 (en) Compounds
AU2001230689A1 (en) Novel compounds
AU2001246864A1 (en) Hypotensors
AU2002216060A1 (en) Novel compounds